deltatrials
Completed PHASE2 NCT00037479

Brain Imaging and Retreatment Study of Persistent Lyme Disease

PET and MRI Imaging of Persistent Lyme Encephalopathy

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Interventions ceftriaxone
Updated 5 times since 2017 Last updated: Dec 6, 2005 Started: Dec 31, 1999

This PHASE2 trial investigates Lyme Disease and Lyme Neuroborreliosis and is currently completed. National Institute of Neurological Disorders and Stroke (NINDS) leads this study, which shows 5 recorded versions since 1999 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Dec 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Neurological Disorders and Stroke (NINDS)
Data source: National Institute of Neurological Disorders and Stroke (NINDS)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • New York, United States